JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Giles, R. E.
Right arrow Articles by Miller, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giles, R. E.
Right arrow Articles by Miller, J. W.
Journal of Pharmacology And Experimental Therapeutics, Vol. 158, Issue 2, 189-194, 1967
Copyright © 1967 by American Society for Pharmacology and Experimental Therapeutics


THE CATECHOL-O-METHYL TRANSFERASE ACTIVITY AND ENDOGENOUS CATECHOLAMINE CONTENT OF VARIOUS TISSUES IN THE RAT AND THE EFFECT OF ADMINISTRATION OF U-0521 (3’,4’-DIHYDROXY-2-METHYL PROPIOPHENONE)

Ralph E. Giles 1 and Jack W. Miller 1

1 Department of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota

The regulatory influence of COMT (catechol-O-methyl transferase) on the catecholamine content of various tissues was investigated. The COMT activity of the heart, brain, uterus and liver was inhibited by administration of U-0521. This agent increased the epinephrine but not the norepinephrine content of the uterus within a period of 1 hr. The norepinephrine concentration in the brain was also elevated but no significant changes occurred in the catecholamine content of the heart. The increases in catecholamines were probably due to the localized inhibition of COMT in the tissues where these changes occurred. The COMT activity of the uterus was greater during estrus as compared to diestrus and increased after estrogen administration to ovariectomized rats. The cyclic variation of the catecholamine content in the uterus could not be explained on the basis of these changes in COMT activity.

Submitted on November 13, 1966
Accepted on June 22, 1967







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1967 by the American Society for Pharmacology and Experimental Therapeutics.